Why ignorance of cybersecurity cuts deep, Oracle stock blows up, Colorado punts amendments and effective date for AI law.

As AI weaves its way into the healthcare ecosystem, Oracle is reshaping the EHR debate to focus on collaboration and interoperability. But will everyone be willing to share?

Sills’ team at Bank of America upgraded Oracle’s shares to Buy from Neutral following the results. Deutsche Bank analysts raised their target price from $240 to $335. It is worth noting that this ...

Gold corrected today, losing 0.42% and hovering around $3625. The move lower in bullion is largely tied to a light technical ...

Oracle's shares rose after strong Q1 results driven by cloud and AI growth and record contracts. Analysts see it as a leader ...

Oracle Corporation's stock surged 36% after management revealed massive new contracts and a backlog jump. Click here to find ...

Wednesday's producer-price index for August, which surprisingly fell 0.1%, is likely to keep the Federal Reserve on track to ...

When Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences took the stage to kick off the Oracle Health and Life Sciences Summit, she set the tone for the days ...

Oracle dazzled Wall Street with AI inference-influenced revenue forecasts, but channel partners should also mind comments on ...

Nutanix was positioned closest to VMware in the "Leaders" quadrant, a spot the firm has been nurturing for some time. It has appeared in Gartner's distributed hybrid infrastructure analysis three ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...